ReCor Medical has presented six-month follow-up data of eight patients treated via renal denervation with the company's Paradise system.
The CE-marked Paradise system for renal denervation is based on ultrasound, not radiofrequency, energy and requires 30 seconds for treating resistant hypertension.
The six months follow-up data showed that systolic blood pressure was reduced by an average of 33 mm Hg in 8 patients.
The data also demonstrated that there were reductions in sustained blood pressure in home and ambulatory measurements at six months.
ReCor Medical CEO Mano Iyer said, "These clinical results strongly suggest a significant competitive advantage for ReCor’s ultrasound-based PARADISE system compared to radiofrequency-based standard of care for treating resistant hypertension patients."